Literature DB >> 827748

Clinical and laboratory investigations of monovalent and combined meningococcal polysaccharide vaccine, groups A and C.

R E Weibel, V M Villarejos, P P Vella, A F Woodhour, A A Mclean, M R Hilleman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 827748     DOI： 10.3181/00379727-153-39563

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  4 in total

1.  Determination of meningococcal antibodies by microassay.

Authors:  F Ambrosch; H Stemberger; G Wiedermann; G Stanek; D Jovanovic
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

2.  Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine.

Authors:  S E Maslanka; J W Tappero; B D Plikaytis; R S Brumberg; J K Dykes; L L Gheesling; K B Donaldson; A Schuchat; J Pullman; M Jones; J Bushmaker; G M Carlone
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.

Authors:  S E Maslanka; L L Gheesling; D E Libutti; K B Donaldson; H S Harakeh; J K Dykes; F F Arhin; S J Devi; C E Frasch; J C Huang; P Kriz-Kuzemenska; R D Lemmon; M Lorange; C C Peeters; S Quataert; J Y Tai; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

4.  Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.

Authors:  F Ambrosch; G Wiedermann; P Crooy; A M George
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.